Page 55 - MI-1-1

Microbes & Immunity The feature of bladder cancer stem cells

120. Gutzmer R, Solomon JA. Hedgehog pathway inhibition Gresham HD, Lindberg FP. Role of CD47 as a marker of
for the treatment of basal cell carcinoma. Target Oncol. self on red blood cells. Science. 2000;288(5473):2051-2054.
2019;14(3):253-267.
doi: 10.1126/science.288.5473.2051
doi: 10.1007/s11523-019-00648-2 132. Bouwstra R, van Meerten T, Bremer E. CD47-SIRPα
121. Di Magno L, Coni S, Di Marcotullio L, Canettieri G. blocking-based immunotherapy: Current and prospective
Digging a hole under Hedgehog: Downstream inhibition therapeutic strategies. Clin Transl Med. 2022;12(8):e943.
as an emerging anticancer strategy. Biochim Biophys Acta. doi: 10.1002/ctm2.943
2015;1856(1):62-72.
133. Kaur S, Cicalese KV, Bannerjee R, Roberts DD.
doi: 10.1016/j.bbcan.2015.06.003
Preclinical and clinical development of therapeutic
122. Jin G, Sivaraman A, Lee K. Development of taladegib as a antibodies targeting functions of CD47 in the tumor
sonic hedgehog signaling pathway inhibitor. Arch Pharm microenvironment. Antib Ther. 2020;3(3):179-192.
Res. 2017;40(12):1390-1393. doi: 10.1093/abt/tbaa017
doi: 10.1007/s12272-017-0987-x
134. Chen SH, Dominik PK, Stanfield J, et al. Dual checkpoint
123. Wang C, Wu H, Katritch V, et al. Structure of the human blockade of CD47 and PD-L1 using an affinity-tuned
smoothened receptor bound to an antitumour agent. bispecific antibody maximizes antitumor immunity.
Nature. 2013;497(7449):338-343. J Immunother Cancer. 2021;9(10):e003464.
doi: 10.1038/nature12167 doi: 10.1136/jitc-2021-003464
124. Hyman JM, Firestone AJ, Heine VM, et al. Small-molecule 135. Chen Y, Wang H, Zuo Y, Li N, Ding M, Li C. A novel
inhibitors reveal multiple strategies for Hedgehog pathway monoclonal antibody KMP1 has potential antitumor
blockade. Proc Natl Acad Sci U S A. 2009;106(33):14132-14137. activity of bladder cancer by blocking CD44 in vivo and
in vitro. Cancer Med. 2018;7(5):2064-2077.
doi: 10.1073/pnas.0907134106
doi: 10.1002/cam4.1446
125. Zhu J, Chen Z, Lallemand-Breitenbach V, de Thé H. How
acute promyelocytic leukaemia revived arsenic. Nat Rev 136. Luo Y, Tian Z, Hua X, et al. Isorhapontigenin (ISO)
Cancer. 2002;2(9):705-713. inhibits stem cell-like properties and invasion of bladder
cancer cell by attenuating CD44 expression. Cell Mol Life
doi: 10.1038/nrc887
Sci. 2020;77(2):351-363.
126. Infante P, Mori M, Alfonsi R, et al. Gli1/DNA interaction doi: 10.1007/s00018-019-03185-3
is a druggable target for Hedgehog-dependent tumors.
EMBO J. 2015;34(2):200-217. 137. Zhuang J, Shen L, Li M, et al. Cancer-associated fibroblast-
derived miR-146a-5p generates a niche that promotes
doi: 10.15252/embj.201489213
bladder cancer stemness and chemoresistance. Cancer Res.
127. Zhu L, Ni C, Dong B, et al. A novel hedgehog inhibitor 2023;83(10):1611-1627.
iG2 suppresses tumorigenesis by impairing self-renewal in doi: 10.1158/0008-5472.Can-22-2213
human bladder cancer. Cancer Med. 2016;5(9):2579-2586.
138. Ma Z, Li X, Mao Y, et al. Interferon-dependent SLC14A1(+)
doi: 10.1002/cam4.802
cancer-associated fibroblasts promote cancer stemness via
128. Willingham SB, Volkmer JP, Gentles AJ, et al. The CD47- WNT5A in bladder cancer. Cancer Cell. 2022;40(12):1550-
signal regulatory protein alpha (SIRPa) interaction is a 1565.e7.
therapeutic target for human solid tumors. Proc Natl Acad
Sci U S A. 2012;109(17):6662-6667. doi: 10.1016/j.ccell.2022.11.005
139. Liang T, Tao T, Wu K, et al. Cancer-associated fibroblast-
doi: 10.1073/pnas.1121623109
induced remodeling of tumor microenvironment
129. Kiss B, van den Berg NS, Ertsey R, et al. CD47-targeted in recurrent bladder cancer. Adv Sci (Weinh).
near-infrared photoimmunotherapy for human bladder 2023;10(31):e2303230.
cancer. Clin Cancer Res. 2019;25(12):3561-3571.
doi: 10.1002/advs.202303230
doi: 10.1158/1078-0432.Ccr-18-3267
140. Luo H, Xia X, Huang LB, et al. Pan-cancer single-cell
130. Jaiswal S, Jamieson CH, Pang WW, et al. CD47 is upregulated analysis reveals the heterogeneity and plasticity of cancer-
on circulating hematopoietic stem cells and leukemia cells associated fibroblasts in the tumor microenvironment.
to avoid phagocytosis. Cell. 2009;138(2):271-285. Nat Commun. 2022;13(1):6619.
doi: 10.1016/j.cell.2009.05.046 doi: 10.1038/s41467-022-34395-2
131. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, 141. Ma C, Yang C, Peng A, et al. Pan-cancer spatially resolved

Volume 1 Issue 1 (2024) 49 doi: 10.36922/mi.2377